Literature DB >> 12367762

Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays.

Stanley S Levinson1, James J Miller.   

Abstract

BACKGROUND: Heterophile antibodies interfere with immunoassays. Understanding the nature and characteristics of these antibodies provides a format for better identifying and removing them. Growing evidence suggests many of these antibodies are natural antibodies. Very large number of tests are being performed with automated analyzers and there has been a problem with misdiagnosis due to interference. New commercial agents for blocking heterophile antibodies have been developed.
METHODS: Review of the immunology and methodological literature with critical interpretation of the findings.
CONCLUSIONS: Heterophile antibodies consist of natural antibodies and autoantibodies. Both types are usually weak antibodies that interfere by noncompetitive mechanisms. Based on very strong circumstantial evidence, we propose that natural antibodies account for most interference with automated immunoassays. In terms of false positive results, the interference rate is very low, about 99.95% accuracy. Specific blocking agents have some theoretical advantage over nonspecific blocking agents, but in actual practice, the very low false positive frequency makes it difficult if not impossible to statistically compare blocking agents or other assay modifications with adequate statistical power. In the absence of a technique that lends itself to automation for removing all immunoglobulins, it appears that infrequent heterophile interference cannot be avoided. Copyright 2002 Elsevier Science B.V.

Mesh:

Substances:

Year:  2002        PMID: 12367762     DOI: 10.1016/s0009-8981(02)00275-9

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  42 in total

Review 1.  Ligand binding assays in the 21st century laboratory: recommendations for characterization and supply of critical reagents.

Authors:  Denise M O'Hara; Valerie Theobald; Adrienne Clements Egan; Joel Usansky; Murli Krishna; Julie TerWee; Mauricio Maia; Frank P Spriggs; John Kenney; Afshin Safavi; Jeannine Keefe
Journal:  AAPS J       Date:  2012-03-14       Impact factor: 4.009

2.  Antituberculosis IgG antibodies as a marker of active Mycobacterium tuberculosis disease.

Authors:  Ryan J Welch; Kathleen M Lawless; Christine M Litwin
Journal:  Clin Vaccine Immunol       Date:  2012-02-01

3.  Performance of a commercial immunoglobulin M antibody capture assay using analyte-specific reagents to screen for interfering factors during a West Nile virus epidemic season in Nebraska.

Authors:  Anthony R Sambol; Steven H Hinrichs; Wayne R Hogrefe; Beth K Schweitzer
Journal:  Clin Vaccine Immunol       Date:  2006-11-22

4.  Heterophile antibodies in horse plasma interfering in an enzyme-linked immunosorbent assay.

Authors:  V Borromeo; A Berrini; D Gaggioli; C Secchi
Journal:  Vet Res Commun       Date:  2007-08       Impact factor: 2.459

5.  Development of a more efficient algorithm for identifying false-positive reactivity results in a dengue virus immunoglobulin M screening assay.

Authors:  Harry E Prince; Cindy Yeh; Mary Lapé-Nixon
Journal:  Clin Vaccine Immunol       Date:  2008-06-18

6.  Evaluation of a new commercial enzyme immunoassay for the detection of IgM antibodies to West Nile virus using a ratio method to eliminate nonspecific reactivity.

Authors:  Ryan J Welch; Brian L Anderson; Christine M Litwin
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

7.  Frequent false positive beta human chorionic gonadotropin tests in immunoglobulin A deficiency.

Authors:  A K Knight; T Bingemann; L Cole; C Cunningham-Rundles
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

8.  Frequency-selective electrokinetic enrichment of biomolecules in physiological media based on electrical double-layer polarization.

Authors:  Ali Rohani; Bankim J Sanghavi; Armita Salahi; Kuo-Tang Liao; Chia-Fu Chou; Nathan S Swami
Journal:  Nanoscale       Date:  2017-08-24       Impact factor: 7.790

9.  Interferences in immunoassay.

Authors:  Jill Tate; Greg Ward
Journal:  Clin Biochem Rev       Date:  2004-05

10.  Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-specific antibodies.

Authors:  Wayne R Hogrefe; Ronald Moore; Mary Lape-Nixon; Michael Wagner; Harry E Prince
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.